SENS - Senseonics Holdings, Inc.


6.105
-0.765   -12.531%

Share volume: 829,979
Last Updated: 03-05-2026
Measuring And Control Equipment/Industrial Measurement Instruments & Related Products: -0.01%

PREVIOUS CLOSE
CHG
CHG%

$6.87
-0.76
-0.11%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
42%
Profitability 35%
Dept financing 43%
Liquidity 75%
Performance 40%
Company vs Stock growth
vs
Performance
5 Days
-26.71%
1 Month
-17.83%
3 Months
-8.61%
6 Months
-2.48%
1 Year
-2.48%
2 Year
-2.48%
Key data
Stock price
$6.10
P/E Ratio 
0.00
DAY RANGE
$6.01 - $6.81
EPS 
-$0.43
52 WEEK RANGE
$5.25 - $8.75
52 WEEK CHANGE
-$2.48
MARKET CAP 
355.038 M
YIELD 
N/A
SHARES OUTSTANDING 
40.858 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$609,619
AVERAGE 30 VOLUME 
$562,670
Company detail
CEO: Timothy T. Goodnow
Region: US
Website: senseonics.com
Employees: 90
IPO year: 2016
Issue type:
Market: XNAS
Industry: Measuring And Control Equipment/Industrial Measurement Instruments & Related Products
Sector: Manufacturing

Senseonics Holdings, Inc. develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. Senseonics is headquartered in Germantown, Maryland, and serves healthcare providers and patients through a network of distributors.

Recent news